Tenaya Therapeutics Inc (TNYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 26,164 | 18,300 | 15,237 | 13,105 | 10,322 |
| Operating Income | -26,164 | -18,300 | -15,237 | -13,105 | -10,322 |
| Other Income | 13 | 38 | 27 | 7 | 4 |
| Pre-tax Income | -26,151 | -18,262 | -15,210 | -13,098 | -10,318 |
| Net Income Continuous | -26,151 | -18,262 | -15,210 | -13,098 | -10,318 |
| Net Income | $-26,151 | $-18,262 | $-15,210 | $-13,098 | $-10,318 |
| EPS Basic Total Ops | 21.77 | -0.68 | -13.26 | -11.93 | -9.85 |
| EPS Basic Continuous Ops | 21.77 | -0.68 | -13.26 | -11.93 | -9.85 |
| EPS Diluted Total Ops | 21.77 | -0.68 | -13.26 | -11.93 | -9.85 |
| EPS Diluted Continuous Ops | 21.77 | -0.68 | -13.26 | -11.93 | -9.85 |
| EBITDA(a) | $-25,248 | $-17,548 | $-14,502 | $-12,416 | $-9,664 |